Search

everythinglearnresearchcommunity

for

Search:↓

The conclusion is that managing androgen excess requires long-term treatment, including hormonal contraceptives and androgen blockers, with follow-up after six months.

The document concludes that early recognition and treatment of PCOS in adolescents is crucial for managing symptoms and long-term health risks.

PCOS affects women's health by increasing the risk of diabetes, heart disease, and reproductive issues.

Acne is caused by genetics, diet, hormones, and bacteria, with treatments not yet curative.

Polycystic Ovary Syndrome is linked to higher risk of hypertension and heart disease.

Lower levels of certain brain chemicals are linked to worse PTSD symptoms in men.

Impaired androgen production in 46,XY DSDs causes ambiguous genitalia and requires long-term care.

Metformin has limited effectiveness for improving PCOS symptoms and lacks clear benefits, needing more research to confirm its efficacy.

Metformin and rosiglitazone both improved insulin use and hormonal symptoms in women with PCOS.

Weight loss and metformin don't significantly change vaspin levels in women with PCOS.

The document suggests that clinical trials for PCOS should focus on meaningful primary outcomes like live birth rates, rather than less reliable surrogate markers.

Insulin-sensitizing drugs like metformin can help with ovulation, weight loss, and lower testosterone in some women with PCOS.

Curcumin may improve blood sugar levels and cholesterol in people with PCOS, but more research is needed.

Higher androstenedione levels in women with PCOS are linked to more severe symptoms.

PCOS is a complex disorder managed by treating symptoms and requires a team of specialists.

Sex hormones affect hair and feather growth and may help manage alopecia and hormone-dependent cancers.

Sebaceous glands play a key role in skin health, immunity, and various skin diseases.

The document concludes that various drugs can manage symptoms and metabolic issues in women with PCOS.

Certain genetic markers linked to reproductive potential were identified by their impact on a protein's ability to bind to genes.

Diagnosing hyperandrogenism in women is complex and requires accurate testing methods and consideration of SHBG levels.

Low-dose anti-androgen drugs and certain drug combinations are effective for hirsutism, and insulin sensitizers show promise, especially for those with polycystic ovarian syndrome.

PCOS is a long-term condition that needs more research for better understanding and treatment.

Metformin helps improve symptoms and reproductive outcomes in people with polycystic ovary syndrome.

Hyperadrenocorticism in ferrets is linked to neutering and indoor housing, and is best treated with surgery and a deslorelin implant.

Genetic defects in testosterone production can cause hormonal and developmental disorders, and more research is needed to understand androgen regulation and develop safer treatments.

Aleglitazar and its major metabolite are safe enough to proceed to Phase 3 clinical trials.

Polycystic Ovary Syndrome (PCOS) is a hormonal disorder in women that can cause infertility and other health issues, and it may be improved by treatments that increase insulin sensitivity.

PCOS in lean women is a serious health condition with implications beyond fertility, affecting metabolism and increasing cardiovascular disease risk.

Acupuncture may improve reproductive and metabolic functions in PCOS without negative side effects, but more research is needed to confirm its effectiveness.

Early treatment of PCOS in teens is crucial to prevent long-term health issues like diabetes and heart disease.